ICH Q12 Post Approval Change Management Protocol: Advantages for Consumers, Regulators and Industry

Posted 16 May 2017 By Ajay Babu Pazhayattil, Naheed Sayeed-Desta, Vijayalakshmi Iyer

placeholder+image This article discusses the latest draft of ICH Q12 and significance of harmonizing regulatory requirements across regional borders. It emphasizes how Post-Approval Change Management Protocol (PACMP) can be used as a tool to improve strategic change management and ensure supply chain reliability.

Share this article:

Categories: Biologics and biotechnology, Drugs, Quality, Features, US, Europe, FDA, ICH

Tags: ICH Q12, Post Approval Change Management Protocol, Quality by Design, QbD

Regulatory Exchange: Latest Updates From the Community